Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.

Schöffski P, Garcia JA, Stadler WM, Gil T, Jonasch E, Tagawa ST, Smitt M, Yang X, Oliner KS, Anderson A, Zhu M, Kabbinavar F. A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma. BJU Int. 2011 Sep; 108(5):679-86.

View in: PubMed

collapse authors with profiles